A Multimodal AI Model May Improve Recurrence Risk Stratification in Early Breast Cancer

New model provided better prognostic information for recurrence in HR-positive, HER2-negative breast cancer than the Oncotype DX 21-gene recurrence score

SAN ANTONIO – An artificial intelligence (AI) model created by integrating clinical,…